Cancer Vaccines
Largest lung cancer study, MAGRIT, shows collective commitment to development of tailored cancer therapy
Published in Vaccine Weekly, August 19th, 2009
Data presented Aug. 6, 2009, at the The International Society of Lung Cancer (IASLC) 13th World Conference on Lung Cancer (WCLC) in San Francisco highlight the screening of over 3,000 patients for MAGRIT (MAGE-A3 as Adjuvant Non-Small Cell LunG CanceR ImmunoTherapy)1, the largest-ever treatment trial in lung cancer. The rapid screening of patients into the MAGRIT trial is unprecedented given so few eligible lung cancer patients (less than 1% in the U.S.2) traditionally enter clinical trials and benefit from the potential hope of novel treatments.
MAGRIT is a phase III study investigating the efficacy of MAGE-A3 (Melanoma AntiGEn-A3) Antigen-Specific Cancer...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2009-08-19)
More Articles from Vaccine Weekly
- Johns Hopkins University Bloomberg School of Public Health
Vaccine blocks malaria transmission in lab experiments - Journal of the National Cancer Institute
AIDS patients face higher risk of HPV-related cancers as immunosuppression grows - Cancer Vaccines
Bellicum Pharmaceuticals Announces Initiation of Phase I/II Clinical Trial of Novel Vaccine for Patients With Advanced Prostate Cancer - Cancer Vaccines
Society of Gynecologic Oncologists Issues White Paper on HPV Vaccine's Impact on Cervical Cancer Prevention - Genetics
Studies from S. Jegouic and co-researchers yield new data on genetics - HIV/AIDS
Reports on HIV/AIDS findings from Y.M. Wan and co-researchers provide new insights - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
